466 filings
Page 9 of 24
8-K
p2vjav8ocjhaw
16 Apr 19
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
8:03am
8-K
2nzg9a1g sxa
12 Apr 19
Amendments to Articles of Incorporation or Bylaws
8:15am
8-K
uxc zgbab5mvzxgvfx
26 Mar 19
Submission of Matters to a Vote of Security Holders
4:13pm
8-K
p0zy oj9fq4uc
11 Mar 19
Regulation FD Disclosure
6:54am
DEFA14A
kdw6lp
11 Mar 19
Additional proxy soliciting materials
6:30am
8-K
g4namhcay62l0g77
6 Mar 19
Departure of Directors or Certain Officers
4:23pm
8-K
47funhm
1 Mar 19
Rexahn Pharmaceuticals Appoints Lara S. Sullivan to its Board of Directors
5:10pm
8-K
07fi 2fqtzlmw
25 Jan 19
Entry into a Material Definitive Agreement
4:51pm
424B5
e0r948thik smhz92bo1
24 Jan 19
Prospectus supplement for primary offering
5:15pm
8-K
20bplnj883blu9ly99
22 Jan 19
Rexahn Presents Updated Preliminary Data on RX-3117 in Pancreatic Cancer
4:48pm
424B5
x8bt apj5l3p
22 Jan 19
Prospectus supplement for primary offering
4:47pm
CT ORDER
lad9owo288r1xbv
17 Dec 18
Confidential treatment order
10:15am
8-K
3zw hk5jmawpg6
3 Dec 18
Rexahn Pharmaceuticals Appoints Gil Price to its Board of Directors
4:53pm
8-K
bqykqa
16 Nov 18
Rexahn Pharmaceuticals Announces Leadership Transition
4:45pm